Guido Lancman, MD, on the Study Design of IVIG in Patients with Multiple Myeloma Receiving ...

Retrieved on: 2020-12-26 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Guido Lancman, MD, on the Study Design of IVIG in Patients with Multiple Myeloma Receiving .... View article details on hiswai:

Excerpt

So, to start off, daratumumab is a CD38 monoclonal antibody. ... production of antibodies or immunoglobulins, known as hypogammaglobulinemia.

Article found on: www.cancernetwork.com